It's a pretty good presentation. It showed why UFI has a place in the space: Ultra-rapid absorption (TINS-50%-early) relative to analogs and regular human insulin (RHI) • Healthy Normal Response: 10 – 15 min • Linjeta™: 8 – 18 min (NDA Formulation: 8 – 13 min) • Humalog®: 25 min • NovoLog®: 23 - 25 min • RHI (Humulin® R): 40 – 55 min I am not sure if the 3 candidates (BIOD-2AA BIOD-2FF BIOD-2HH) are variations from one analog or 3 different analogs.